KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Acquisitions (2021 - 2024)

Ginkgo Bioworks Holdings (DNA) has disclosed Acquisitions for 1 consecutive years, with -$9.3 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Acquisitions changed N/A year-over-year to -$9.3 million, compared with a TTM value of -$9.3 million through Sep 2023, changed N/A, and an annual FY2024 reading of $5.4 million, changed N/A over the prior year.
  • Acquisitions was -$9.3 million for Q4 2021 at Ginkgo Bioworks Holdings, down from $20.2 million in the prior quarter.
  • Across five years, Acquisitions topped out at $20.2 million in Q3 2021 and bottomed at -$9.3 million in Q4 2021.